During the last session, Applied Therapeutics Inc (NASDAQ:APLT)’s traded shares were 2.69 million, with the beta value of the company hitting 1.87. At the end of the trading day, the stock’s price was $0.54, reflecting an intraday loss of -6.07% or -$0.04. The company’s market capitalization is $62.99M, and the average intraday trading volume over the past 10 days was 2.48 million shares, and the average trade volume was 7.04 million shares over the past three months.
Applied Therapeutics Inc (APLT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.17. APLT has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.19.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Applied Therapeutics Inc (APLT) registered a -6.07% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.07% in intraday trading to $0.54, hitting a weekly high. The stock’s 5-day price performance is -10.85%, and it has moved by -21.66% in 30 days. Based on these gigs, the overall price performance for the year is -80.53%. The short interest in Applied Therapeutics Inc (NASDAQ:APLT) is 21.08 million shares and it means that shorts have 3.45 day(s) to cover.
The consensus price target of analysts on Wall Street is $4.5, which implies an increase of 88.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4 and $5 respectively. As a result, APLT is trading at a discount of -825.93% off the target high and -640.74% off the low.
Applied Therapeutics Inc (APLT) estimates and forecasts
In the rating firms’ projections, revenue will decrease -94.66% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 100k as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 12.32M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -8.72%. While earnings are projected to return 1.41% in 2025, the next five years will return 41.84% per annum.
APLT Dividends
Applied Therapeutics Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 9.54 million shares, is of VR ADVISER, LLC’s that is approximately 66.1112% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $44.57 million.
